- Home
- ZDAI vs PHIO Comparison
ZDAI vs PHIO Comparison
Compare ZDAI & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDAI
- PHIO
- Stock Information
- Founded
- ZDAI 2022
- PHIO 2011
- Country
- ZDAI Hong Kong
- PHIO United States
- Employees
- ZDAI N/A
- PHIO N/A
- Industry
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- ZDAI Consumer Discretionary
- PHIO Health Care
- Exchange
- ZDAI Nasdaq
- PHIO Nasdaq
- Market Cap
- ZDAI 15.6M
- PHIO 13.7M
- IPO Year
- ZDAI 2024
- PHIO N/A
- Fundamental
- Price
- ZDAI N/A
- PHIO $2.35
- Analyst Decision
- ZDAI
- PHIO Strong Buy
- Analyst Count
- ZDAI 0
- PHIO 3
- Target Price
- ZDAI N/A
- PHIO $10.67
- AVG Volume (30 Days)
- ZDAI 5.5M
- PHIO 161.3K
- Earning Date
- ZDAI 10-17-2025
- PHIO 11-13-2025
- Dividend Yield
- ZDAI N/A
- PHIO N/A
- EPS Growth
- ZDAI N/A
- PHIO N/A
- EPS
- ZDAI N/A
- PHIO N/A
- Revenue
- ZDAI $19,275,673.00
- PHIO N/A
- Revenue This Year
- ZDAI N/A
- PHIO N/A
- Revenue Next Year
- ZDAI N/A
- PHIO N/A
- P/E Ratio
- ZDAI N/A
- PHIO N/A
- Revenue Growth
- ZDAI 43.16
- PHIO N/A
- 52 Week Low
- ZDAI $0.37
- PHIO $0.97
- 52 Week High
- ZDAI $107.36
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- ZDAI 57.78
- PHIO 56.18
- Support Level
- ZDAI $0.63
- PHIO $2.30
- Resistance Level
- ZDAI $0.70
- PHIO $2.45
- Average True Range (ATR)
- ZDAI 0.06
- PHIO 0.12
- MACD
- ZDAI -0.00
- PHIO 0.02
- Stochastic Oscillator
- ZDAI 51.77
- PHIO 62.26
About ZDAI Primega Group Holdings Limited Ordinary Shares
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.